2025 annual financial data
Dyne Therapeutics, Inc. 2025 Operating margin
Dyne Therapeutics, Inc. 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -468,184,000 USD and net income was -446,214,000 USD.
Operating cash flow was -403,207,000 USD.
Get free Dyne Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -468,184,000 USD
- Net income
- -446,214,000 USD
- Operating cash flow
- -403,207,000 USD